Improvement of defective bactericidal capacity of polymorphonuclear leukocytes by isoniazide in a case of chronic granulomatous disease.
D001770:Blood Bactericidal Activity / Q000187:drug effects*; D004338:Drug Combinations / Q000627:therapeutic use; D006105:Granulomatous Disease, Chronic / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007538:Isoniazid / Q000627:therapeutic use*; D008297:Male; D009504:Neutrophils / Q000187:drug effects*; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole; D007538:Isoniazid